Stockholm-based Elekta secures €100 million EIB loan to advance cancer and neurological treatments
Stockholm-based HealthTech company Elekta has secured a loan of up to €100 million from the European Investment Bank (EIB), the European Union’s financing arm. The financing falls under the EIB Group’s TechEU programme, which is designed to strengthen European investment in strategic tec
<p>Stockholm-based HealthTech company Elekta has secured a loan of up to €100 million from the European Investment Bank (EIB), the European Union’s financing arm. The financing falls under the EIB Group’s TechEU programme, which is designed to strengthen European investment in strategic tec</p>